{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T17:33:57Z","timestamp":1770226437475,"version":"3.49.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":1070,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T00:00:00Z","timestamp":1676937600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Evidence supporting the effectiveness of therapeutic protocols for nonassociative immune-mediated hemolytic anemia (na-IMHA) is weak.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis\/Objectives<\/jats:title>\n                    <jats:p>Investigate the efficacy of various drugs in na-IMHA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Animals<\/jats:title>\n                    <jats:p>Two hundred forty-two dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Multi-institutional retrospective study (2015-2020). Immunosuppressive effectiveness was determined by time to packed cell volume (PCV) stabilization and duration of hospitalization through analysis by mixed model linear regression. Occurrence of disease relapse, death, and antithrombotic effectiveness, were analyzed using mixed model logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Use of corticosteroids vs a multi-agent protocol had no effect on time to PCV stabilization (P\u00a0=\u00a0.55), duration of hospitalization (P\u00a0=\u00a0.13), or case fatality (P\u00a0=\u00a0.06). A higher rate of relapse (P\u00a0=\u00a0.04; odds ratio: 3.97; 95% confidence interval [CI]: 1.06-14.8) was detected in dogs receiving corticosteroids (11.3%) during follow-up (median: 28.5\u2009days, range: 0-1631\u2009days) compared to multiple agents (3.1%) during follow up (median: 47.0\u2009days, range: 0-1992\u2009days). When comparing drug protocols, there was no effect on time to PCV stabilization (P\u00a0=\u00a0.31), relapse (P\u00a0=\u00a0.44), or case fatality (P\u00a0=\u00a0.08). Duration of hospitalization was longer, by 1.8\u2009days (95% CI: 0.39-3.28\u2009days), for the corticosteroid with mycophenolate mofetil group (P\u00a0=\u00a0.01) compared to corticosteroids alone. Use of clopidogrel vs multiple agents had no effect on development of thromboses (P\u2009\u2265\u2009.36).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Clinical Importance<\/jats:title>\n                    <jats:p>Addition of a second immunosuppressive agent did not alter immediate outcome measures but might be associated with a reduction in relapse. Use of multiple antithrombotic agents did not reduce incidence of thrombosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.16652","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T13:10:02Z","timestamp":1676985002000},"page":"528-536","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Retrospective analysis of immunosuppressive and anti-thrombotic protocols in nonassociative immune mediated hemolytic anemia in dogs"],"prefix":"10.1093","volume":"37","author":[{"given":"Jennifer","family":"Weng","sequence":"first","affiliation":[{"name":"College of Veterinary Medicine, Michigan State University Department of Small Animal Clinical Sciences, , East Lansing, Michigan 48824,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyssa A.","family":"Levy","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Michigan State University Department of Small Animal Clinical Sciences, , East Lansing, Michigan 48824,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haley Y.","family":"Abbott","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Michigan State University Department of Small Animal Clinical Sciences, , East Lansing, Michigan 48824,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose A.","family":"Mix","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Michigan State University Department of Small Animal Clinical Sciences, , East Lansing, Michigan 48824,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert W.","family":"Wills","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Mississippi State University Department of Pathobiology and Population Medicine, , Mississippi State, Mississippi 39762,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-0198","authenticated-orcid":false,"given":"Andrew J.","family":"Mackin","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Mississippi State University Department of Clinical Sciences, , Mississippi State, Mississippi 39762,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5678-8923","authenticated-orcid":false,"given":"John M.","family":"Thomason","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Mississippi State University Department of Clinical Sciences, , Mississippi State, Mississippi 39762,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0236-2307","authenticated-orcid":false,"given":"Harry","family":"Cridge","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Michigan State University Department of Small Animal Clinical Sciences, , East Lansing, Michigan 48824,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"key":"2026020302545414100_jvim16652-bib-0001","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/jvim.15463","article-title":"ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs","volume":"33","author":"Swann","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020302545414100_jvim16652-bib-0002","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1746-6148-7-15","article-title":"Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study","volume":"7","author":"Piek","year":"2011","journal-title":"BMC Vet Res"},{"key":"2026020302545414100_jvim16652-bib-0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257700","article-title":"Cross-sectional study of approaches to diagnosis and management of dogs with immune-mediated haemolytic anaemia in primary care and referral veterinary practices in the United Kingdom","volume":"16","author":"Swann","year":"2021","journal-title":"PLoS One"},{"key":"2026020302545414100_jvim16652-bib-0004","first-page":"32","article-title":"Increased risk of select glucocorticoid adverse events in dogs of higher body weight","volume":"63","author":"Sri-Jayantha","year":"2022","journal-title":"Can Vet J"},{"key":"2026020302545414100_jvim16652-bib-0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fvets.2020.00515","article-title":"Side effects to systemic glucocorticoid therapy in dogs under primary veterinary care in the UK","volume":"7","author":"Elkholly","year":"2020","journal-title":"Front Vet Sci"},{"key":"2026020302545414100_jvim16652-bib-0006","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/vr.105104","article-title":"Randomised controlled trial of fractionated and unfractionated prednisolone regimens for dogs with immune-mediated haemolytic anaemia","volume":"184","author":"Swann","year":"2019","journal-title":"Vet Rec"},{"key":"2026020302545414100_jvim16652-bib-0007","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2460\/javma.1989.195.02.246","article-title":"Pulmonary thromboembolism associated with immune-mediated hemolytic anemia in dogs: ten cases (1982-1987)","volume":"195","author":"Klein","year":"1989","journal-title":"J Am Vet Med Assoc"},{"key":"2026020302545414100_jvim16652-bib-0008","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5326\/15473317-37-3-220","article-title":"Hemostatic abnormalities in dogs with primary immune-mediated hemolytic anemia","volume":"37","author":"Scott-Moncrieff","year":"2001","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020302545414100_jvim16652-bib-0009","first-page":"504","article-title":"Prognostic factors for mortality and thromboembolism in canine immune-mediated hemolytic anemia: a retrospective study of 72 dogs","volume":"16","author":"Carr","year":"2002","journal-title":"J Vet Intern Med"},{"key":"2026020302545414100_jvim16652-bib-0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/vec.12791","article-title":"Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): domain 2-defining rational therapeutic usage","volume":"29","author":"Goggs","year":"2019","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020302545414100_jvim16652-bib-0011","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/jvim.15441","article-title":"ACVIM consensus statement on the diagnosis of immune-mediated hemolytic anemia in dogs and cats","volume":"33","author":"Garden","year":"2019","journal-title":"J Vet Intern Med"},{"key":"2026020302545414100_jvim16652-bib-0012","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/jvim.16315","article-title":"The use of high-dose immunoglobulin M-enriched human immunoglobulin in dogs with immune-mediated hemolytic anemia","volume":"36","author":"Bestwick","year":"2022","journal-title":"J Vet Intern Med"},{"key":"2026020302545414100_jvim16652-bib-0013","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jvim.12514","article-title":"Systematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemia","volume":"29","author":"Swann","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020302545414100_jvim16652-bib-0014","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1292\/jvms.09-0283","article-title":"Evaluation of prognostic factors and establishment of a prognostic scoring system for canine primary immune-mediated hemolytic anemia","volume":"72","author":"Ishihara","year":"2010","journal-title":"J Vet Med Sci"},{"key":"2026020302545414100_jvim16652-bib-0015","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5326\/15473317-35-5-384","article-title":"Immune-mediated hemolytic anemia: 70 cases (1988-1996)","volume":"35","author":"Reimer","year":"1999","journal-title":"J Am Anim Hosp Assoc"},{"key":"2026020302545414100_jvim16652-bib-0016","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/jvim.13642","article-title":"Predicting outcome in dogs with primary immune-mediated hemolytic anemia: results of a multicenter case registry","volume":"29","author":"Goggs","year":"2015","journal-title":"J Vet Intern Med"},{"key":"2026020302545414100_jvim16652-bib-0017","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1939-1676.2008.0060.x","article-title":"Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs","volume":"22","author":"Piek","year":"2008","journal-title":"J Vet Intern Med"},{"key":"2026020302545414100_jvim16652-bib-0018","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1748-5827.2011.01074.x","article-title":"Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs","volume":"52","author":"Swann","year":"2011","journal-title":"J Small Anim Pract"},{"key":"2026020302545414100_jvim16652-bib-0019","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/avj.12875","article-title":"Primary immune-mediated haemolytic anaemia: a retrospective long-term study in 61 dogs","volume":"97","author":"Weingart","year":"2019","journal-title":"Aust Vet J"},{"key":"2026020302545414100_jvim16652-bib-0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jsap.12107","article-title":"Treatment of canine idiopathic immune-mediated haemolytic anaemia with mycophenolate mofetil and glucocorticoids: 30 cases (2007 to 2011)","volume":"54","author":"Wang","year":"2013","journal-title":"J Small Anim Pract"},{"key":"2026020302545414100_jvim16652-bib-0021","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2460\/javma.2001.218.1308","article-title":"Correlation between leukocytosis and necropsy findings in dogs with immune-mediated hemolytic anemia: 34 cases (1994-1999)","volume":"218","author":"McManus","year":"2001","journal-title":"J Am Vet Med Assoc"},{"key":"2026020302545414100_jvim16652-bib-0022","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/jsap.12185","article-title":"Comparison of computed tomography pulmonary angiography and point-of-care tests for pulmonary thromboembolism diagnosis in dogs","volume":"55","author":"Goggs","year":"2014","journal-title":"J Small Anim Pract"},{"key":"2026020302545414100_jvim16652-bib-0023","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1939-1676.2010.0505.x","article-title":"Treatment of immune-mediated hemolytic anemia with individually adjusted heparin dosing in dogs","volume":"24","author":"Helmond","year":"2010","journal-title":"J Vet Intern Med"},{"key":"2026020302545414100_jvim16652-bib-0024","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/vec.12794","article-title":"Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): domain 4-refining and monitoring antithrombotic therapies","volume":"29","author":"Sharp","year":"2019","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020302545414100_jvim16652-bib-0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/vec.12286","article-title":"Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases","volume":"25","author":"Panek","year":"2015","journal-title":"J Vet Emerg Crit Care"},{"key":"2026020302545414100_jvim16652-bib-0026","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.tvjl.2016.01.018","article-title":"Enoxaparin has no significant anticoagulation activity in healthy Beagles at a dose of 0.8 mg\/kg four times daily","volume":"210","author":"Pouzot-Nevoret","year":"2016","journal-title":"Vet J"},{"key":"2026020302545414100_jvim16652-bib-0027","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/jvp.13015","article-title":"Anticoagulant profile of subcutaneous enoxaparin in healthy dogs","volume":"45","author":"Frum","year":"2022","journal-title":"J Vet Pharmacol Ther"},{"key":"2026020302545414100_jvim16652-bib-0028","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1939-165X.2011.00364.x","article-title":"Effect of prednisone administration on coagulation variables in healthy Beagle dogs","volume":"40","author":"Rose","year":"2011","journal-title":"Vet Clin Pathol"},{"key":"2026020302545414100_jvim16652-bib-0029","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2460\/ajvr.73.10.1569","article-title":"Effects of oral prednisone administration with or without ultralow-dose acetylsalicylic acid on coagulation parameters in healthy dogs","volume":"73","author":"O'Kell","year":"2012","journal-title":"Am J Vet Res"},{"key":"2026020302545414100_jvim16652-bib-0030","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/j.1939-1676.2012.01025.x","article-title":"The effects of cyclosporine on platelet function and cyclooxygenase expression in normal dogs","volume":"26","author":"Thomason","year":"2012","journal-title":"J Vet Intern Med"},{"key":"2026020302545414100_jvim16652-bib-0031","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/jvim.13960","article-title":"The effects of cyclosporine and aspirin on platelet function in normal dogs","volume":"30","author":"Thomason","year":"2016","journal-title":"J Vet Intern Med"},{"key":"2026020302545414100_jvim16652-bib-0032","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1111\/jvim.15132","article-title":"Effects of immunosuppressive agents on the hemostatic system in normal dogs","volume":"32","author":"Thomason","year":"2018","journal-title":"J Vet Intern Med"},{"key":"2026020302545414100_jvim16652-bib-0033","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1111\/jvim.15945","article-title":"Effect of dilution of canine blood samples on the specificity of saline agglutination tests for immune-mediated hemolysis","volume":"34","author":"Sun","year":"2020","journal-title":"J Vet Intern Med"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jvim.16652","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jvim.16652","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/37\/2\/528\/66656981\/jvim16652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/37\/2\/528\/66656981\/jvim16652.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:55:04Z","timestamp":1770105304000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/37\/2\/528\/8447748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.16652","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3]]},"published":{"date-parts":[[2023,3,1]]},"assertion":[{"value":"2022-04-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-01","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}